Liver (Neoplasia)

LE WE PMID CA

Liver (Neoplasia)

1558

Leber (Neubildung)

Biliary system (Neoplasia)

Chromophobe hepatocellular carcinoma with abrupt anaplasia

Genetics (Microsatellite)

Glomus tumor

Glypican

Hepatic epithelioid haemangioendothelioma

Hepatic solitary fibrous tumor

Hepatitis B

Hepatitis C

IGF1

Infantile hepatic hemangioendothelioma

Inflammatory myofibroblastic tumor

Inflammatory pseudo tumor of the liver

Inflammatory pseudotumor

Intestines (Malformation)

Liver (Biopsy)

Liver (Cirrhosis)

Liver (Focal nodular hyperplasia)

Liver (Metastasis)

Liver (MRT)

Liver (Neoplasia)

Liver (Sonography)

Liver (Transplantation)

Mesothelin

Neoplasia (Carcinogenesis)

Neoplasia (Radiofrequency ablation)

Nested stromal epithelial tumour of the liver

Neuroendocrine System (Neoplasia Carcinoid)

Neuroendocrine system (Neoplasia)

Pancreas (Neoplasia)

Solitary fibrous tumor of the liver

Trans arterial chemoembolization

Ultrasound (Toxicity and therapeutic use)

1998 1	Hepatocarcinogenesis in liver cirrhosis: imaging diagnosis. [9610609] J Korean Med Sci 13(2): 103-16 (1998)
2008 2	Therapeutical concepts and results for Klatskin tumors. [19633782] Dtsch Arztebl Int 105(9): 156-61 (2008)
2008 3	Evolving therapies in the treatment of hepatocellular carcinoma. [19707376] Biologics 2(3): 453-62 (2008)
2007 4	Surveillance of cirrhosis for hepatocellular carcinoma: systematic review and economic analysis. [17767898] Health Technol Assess 11(34): 1-206 (2007)
2008 5	Sorafenib, a systemic therapy for hepatocellular carcinoma. [18376365] Ann Hepatol 7(1): 46-51 (2008)
2006 6	Focal nodular hyperplasia and hepatic adenoma: a review. [17060885] Ann Hepatol 5(3): 206-11 (2006)
2006 7	Hepatocellular carcinoma. An overview. [16531960] Ann Hepatol 5(1): 16-24 (2006)
2007 8	Molecular Pathogenesis of Hepatitis-B-virus-associated Hepatocellular Carcinoma. [20485626] Gut Liver 1(2): 101-17 (2007)
2008 9	A case of primary small cell carcinoma of the liver that was treated with chemotherapy. [19669327] Hepatol Int 2(4): 500-4 (2008)
2008 10	Hepatocellular adenoma: what is new in 2008. [19669260] Hepatol Int 2(3): 316-21 (2008)
1996 11	Hepatobiliary cystadenomas and cystadenocarcinoma. Report of five cases. [8871248] HPB Surg 9(2): 83-92 (1996)
1989 12	Surgery of liver tumours. [2562131] HPB Surg 1(3): 173-84 (1989)
1988 13	Fibrolamellar carcinoma of the liver--a case report from Japan and a review of the literature. [2856433] HPB Surg 1(1): 77-80 (1988)
2006 14	Radiofrequency ablation of liver tumors: a systematic review. [16490897] Arch Surg 141(2): 181-90 (2006)
2006 15	Spontaneous rupture of hepatocellular carcinoma: a systematic review. [16490898] Arch Surg 141(2): 191-8 (2006)
2004 16	Hepatic resection and transplantation for primary carcinoid tumors of the liver. [14745329] Ann Surg 239(2): 210-9 (2004)
2000 17	Risk factors, prevention, and management of postoperative recurrence after resection of hepatocellular carcinoma. [10862190] Ann Surg 232(1): 10-24 (2000)
2000 18	Liver adenomatosis: reappraisal, diagnosis, and surgical management: eight new cases and review of the literature. [10636105] Ann Surg 231(1): 74-81 (2000)
1994 19	Current treatment modalities for hepatocellular carcinoma. [8147605] Ann Surg 219(3): 236-47 (1994)
1987 20	Cavernous hemangioma of the liver. A single institution report of 16 resections. [3555360] Ann Surg 205(5): 456-65 (1987)
1985 21	Fibrolamellar carcinoma of the liver. Review of three cases and the presentation of a characteristic set of tumor markers defining this tumor. [2409935] Ann Surg 202(1): 36-41 (1985)
2007 22	Predictors of outcome in patients with unresectable hepatocellular carcinoma receiving transcatheter arterial chemoembolization. [17635374] Aliment Pharmacol Ther 26(3): 393-400 (2007)
2006 23	Systematic review: evidence-based management of hepatocellular carcinoma--an updated analysis of randomized controlled trials. [16696801] Aliment Pharmacol Ther 23(11): 1535-47 (2006)
2006 24	Survival of patients with early hepatocellular carcinoma treated by percutaneous alcohol injection. [16629938] Aliment Pharmacol Ther 23(9): 1329-35 (2006)
2003 25	Meta-analysis: evaluation of adjuvant therapy after curative liver resection for hepatocellular carcinoma. [12755838] Aliment Pharmacol Ther 17(10): 1247-61 (2003)
2002 26	Non-surgical treatment of hepatocellular carcinoma. [11856073] Aliment Pharmacol Ther 16(1): 1-15 (2002)
1998 27	Review article: Overview of medical treatments in unresectable hepatocellular carcinoma--an impossible meta-analysis? [9692685] Aliment Pharmacol Ther 12(2): 111-26 (1998)
2010 28	Review article: the management of hepatocellular carcinoma. [19925500] Aliment Pharmacol Ther 31(4): 461-76 (2010)
2009 29	Meta-analysis: surveillance with ultrasound for early-stage hepatocellular carcinoma in patients with cirrhosis. [19392863] Aliment Pharmacol Ther 30(1): 37-47 (2009)
2008 30	Review article: pharmacological therapy for hepatocellular carcinoma with sorafenib and other oral agents. [18808443] Aliment Pharmacol Ther 28(11-12): 1269-77 (2008)
2008 31	Review article: the evaluation of solitary liver masses. [18643922] Aliment Pharmacol Ther 28(8): 953-65 (2008)
2003 32	Review article: liver transplantation for HCC. Treatment options on the waiting list. [12786626] Aliment Pharmacol Ther 17 Suppl 2(-): 145-50 (2003)
2003 33	Review article: liver transplantation for hepatocellular carcinoma. [12786625] Aliment Pharmacol Ther 17 Suppl 2(-): 138-44 (2003)
2003 34	Review article: hepatocellular carcinoma: indications for liver transplantation. [12786624] Aliment Pharmacol Ther 17 Suppl 2(-): 130-7 (2003)
2003 35	Liver resection for hepatocellular carcinoma in cirrhotics and noncirrhotics. Evaluation of clinicopathologic features and comparison of risk factors for long-term survival and tumour recurrence in a single centre. [12786623] Aliment Pharmacol Ther 17 Suppl 2(-): 119-29 (2003)
2003 36	Review article: intra-arterial treatments in patients with hepatocellular carcinoma. [12786622] Aliment Pharmacol Ther 17 Suppl 2(-): 111-8 (2003)
2003 37	Review article: percutaneous treatment of hepatocellular carcinoma. [12786621] Aliment Pharmacol Ther 17 Suppl 2(-): 103-10 (2003)
2003 38	Review article: natural history and prognostic prediction of patients with hepatocellular carcinoma. [12786620] Aliment Pharmacol Ther 17 Suppl 2(-): 98-102 (2003)
2003 39	Review article: diagnosis and treatment of Helicobacter: a 2002 updated review. [12786619] Aliment Pharmacol Ther 17 Suppl 2(-): 89-97 (2003)
2009 40	Early and very early hepatocellular carcinoma: when and how much do staging and choice of treatment really matter? A multi-center study. [19171074] BMC Cancer 9(-): 33 (2009)
2008 41	Hepatocellular carcinoma: ESMO clinical recommendations for diagnosis, treatment and follow-up. [18456757] Ann Oncol 19 Suppl 2(-): ii27-8 (2008)
2001 42	Hepatocellular carcinoma. [11300318] Ann Oncol 12(2): 161-72 (2001)
1997 43	Treatment of hepatocellular carcinoma: a systematic review of randomized controlled trials. [9093719] Ann Oncol 8(2): 117-36 (1997)
2008 44	Development of sorafenib and other molecularly targeted agents in hepatocellular carcinoma. [18041064] Cancer 112(2): 250-9 (2008)
2007 45	Ductular reaction is helpful in defining early stromal invasion, small hepatocellular carcinomas, and dysplastic nodules. [17279586] Cancer 109(5): 915-23 (2007)
2006 46	Primary malignant hepatic epithelioid hemangioendothelioma: a comprehensive review of the literature with emphasis on the surgical therapy. [17019735] Cancer 107(9): 2108-21 (2006)
2005 47	Proton beam therapy for hepatocellular carcinoma with portal vein tumor thrombus. [15981284] Cancer 104(4): 794-801 (2005)
2005 48	Use of tamoxifen in advanced-stage hepatocellular carcinoma. A systematic review. [15744746] Cancer 103(7): 1408-14 (2005)
2003 49	Fibrolamellar hepatocellular carcinoma in children and adolescents. [12673731] Cancer 97(8): 2006-12 (2003)
2010 50	Systemic therapy for advanced hepatocellular carcinoma: past, present, and future. [20404795] Cancer Control 17(2): 120-9 (2010)
2010 51	Stereotactic body radiation therapy for liver metastases and primary hepatocellular carcinoma: normal tissue tolerances and toxicity. [20404794] Cancer Control 17(2): 111-9 (2010)
2010 52	Nonsurgical options for hepatocellular carcinoma: evolving role of external beam radiotherapy. [20404793] Cancer Control 17(2): 100-10 (2010)
2010 53	Interventional radiological treatment of hepatocellular carcinoma. [20404792] Cancer Control 17(2): 87-99 (2010)
2010 54	Liver transplantation for hepatocellular carcinoma. [20404791] Cancer Control 17(2): 83-6 (2010)
2010 55	Imaging of the liver for hepatocellular cancer. [20404790] Cancer Control 17(2): 72-82 (2010)
2008 56	Transcatheter arterial chemoembolization and percutaneous ethanol injection for Hepatocellular carcinoma: a retrospective review of the Veterans Affairs Caribbean Healthcare System. [18094664] Cancer Control 15(1): 80-5 (2008)
2009 57	Associations between hepatitis B virus mutations and the risk of hepatocellular carcinoma: a meta-analysis. [19574418] J Natl Cancer Inst 101(15): 1066-82 (2009)
2008 58	Hepatitis B virus genotype and mutants: risk factors for hepatocellular carcinoma. [18695130] J Natl Cancer Inst 100(16): 1121-3 (2008)
2009 59	Sorafenib for the treatment of unresectable hepatocellular carcinoma. [19144678] Oncologist 14(1): 95-100 (2009)
2008 60	Liver tumors in children. [18644850] Oncologist 13(7): 812-20 (2008)
2007 61	Presurgical chemotherapy in patients being considered for liver resection. [17673614] Oncologist 12(7): 825-39 (2007)
1976 62	Precursor lesions for liver cancer in humans. [776394] Cancer Res 36(7 PT 2): 2579-83 (1976)
2004 63	Microsatellite instability mutator phenotype in hepatocellular carcinoma in non-alcoholic and non-virally infected normal livers. [14656944] Carcinogenesis 25(4): 541-7 (2004)
1974 64	Hepatoma--nature's model tumor. A review. [4358463] Am J Pathol 74(1): 179-210 (1974)
2002 65	Ablative therapy for liver tumours. [11950826] Gut 50(5): 733-9 (2002)
2009 66	The current role of neoadjuvant/adjuvant/chemoprevention therapy in partial hepatectomy for hepatocellular carcinoma: a systematic review. [19357024] Hepatobiliary Pancreat Dis Int 8(2): 124-33 (2009)
2008 67	Hepatocellular carcinoma: current management and recent advances. [18522878] Hepatobiliary Pancreat Dis Int 7(3): 237-57 (2008)
2007 68	Specific molecular markers in hepatocellular carcinoma. [17548245] Hepatobiliary Pancreat Dis Int 6(3): 241-7 (2007)
2006 69	Local injection therapy for hepatocellular carcinoma. [16481276] Hepatobiliary Pancreat Dis Int 5(1): 16-21 (2006)
2003 70	Molecular therapy and prevention of hepatocellular carcinoma. [14599923] Hepatobiliary Pancreat Dis Int 2(1): 11-22 (2003)
2008 71	Molecular targeted therapies in hepatocellular carcinoma. [18821591] Hepatology 48(4): 1312-27 (2008)
2000 72	Hepatocellular carcinoma. [10622772] Postgrad Med J 76(891): 4-11 (2000)
2009 73	131-iodine Lipiodol therapy in hepatocellular carcinoma. [19521315] Q J Nucl Med Mol Imaging 53(3): 348-55 (2009)
2009 74	Yttrium-90 radioembolization using TheraSphere in the management of primary and secondary liver tumors. [19521310] Q J Nucl Med Mol Imaging 53(3): 311-6 (2009)
2009 75	Current management strategy of hepatocellular carcinoma. [19598295] World J Gastroenterol 15(26): 3210-6 (2009)
2009 76	Diagnosis of hepatocellular carcinoma. [19294759] World J Gastroenterol 15(11): 1301-14 (2009)
2009 77	Imaging of liver cancer. [19294758] World J Gastroenterol 15(11): 1289-300 (2009)
2009 78	Features of hepatocellular carcinoma in cases with autoimmune hepatitis and primary biliary cirrhosis. [19132775] World J Gastroenterol 15(2): 231-9 (2009)
2008 79	Laser ablation of hepatocellular carcinoma--a review. [19084930] World J Gastroenterol 14(47): 7170-4 (2008)
2008 80	Hepatocellular carcinoma: epidemiology, risk factors and pathogenesis. [18666317] World J Gastroenterol 14(27): 4300-8 (2008)
2008 81	Cystic tumors of the liver: a practical approach. [18595127] World J Gastroenterol 14(23): 3616-20 (2008)
2008 82	Chemotherapy with enteric-coated tegafur/uracil for advanced hepatocellular carcinoma. [18473401] World J Gastroenterol 14(18): 2797-801 (2008)
2008 83	DNA methylation in hepatocellular carcinoma. [18350605] World J Gastroenterol 14(11): 1741-8 (2008)
2008 84	Current role of ultrasound for the management of hepatocellular carcinoma. [18350602] World J Gastroenterol 14(11): 1710-9 (2008)
2008 85	Reactivation of the insulin-like growth factor-II signaling pathway in human hepatocellular carcinoma. [18350600] World J Gastroenterol 14(11): 1690-8 (2008)
2008 86	Radioembolization for the treatment of unresectable hepatocellular carcinoma: a clinical review. [18350597] World J Gastroenterol 14(11): 1664-9 (2008)
2008 87	Surgical treatment of hepatocellular carcinoma: evidence-based outcomes. [18205256] World J Gastroenterol 14(5): 685-92 (2008)
2006 88	Serum tumor markers for detection of hepatocellular carcinoma. [16534867] World J Gastroenterol 12(8): 1175-81 (2006)
2005 89	Hepatocellular carcinoma: therapy and prevention. [16437707] World J Gastroenterol 11(47): 7391-400 (2005)
2002 90	Radiofrequence ablation of liver cancers. [12046057] World J Gastroenterol 8(3): 393-9 (2002)
2001 91	Hepatocellular carcinoma--cause, treatment and metastasis. [11819809] World J Gastroenterol 7(4): 445-54 (2001)
2008 92	Molecular mechanisms of hepatocellular carcinoma. [19003900] Hepatology 48(6): 2047-63 (2008)
2004 93	AASLD single-topic research conference on hepatocellular carcinoma: Conference proceedings. [15565604] Hepatology 40(6): 1465-73 (2004)
2003 94	Systematic review of randomized trials for unresectable hepatocellular carcinoma: Chemoembolization improves survival. [12540794] Hepatology 37(2): 429-42 (2003)
2004 95	Liver ablation therapy. [15447955] Br J Radiol 77(921): 713-23 (2004)
2004 96	Systematic review of radiological imaging for hepatocellular carcinoma in cirrhotic patients. [15326039] Br J Radiol 77(920): 633-40 (2004)
2006 97	Unusual mesenchymal liver tumors in adults: radiologic-pathologic correlation. [17056878] AJR Am J Roentgenol 187(5): W481-9 (2006)
2006 98	Contrast-enhancing hepatic eosinophilic abscess during the hepatic arterial phase: a mimic of hepatocellular carcinoma. [16357397] AJR Am J Roentgenol 186(1): 168-73 (2006)
2003 99	Interpretation of CT and MRI after radiofrequency ablation of hepatic malignancies. [14627588] AJR Am J Roentgenol 181(6): 1635-40 (2003)
2001 100	Radiofrequency ablation of the liver: current status. [11133529] AJR Am J Roentgenol 176(1): 3-16 (2001)
1997 101	Detection of hepatocellular carcinoma in patients with cirrhosis: MR imaging versus angiographically assisted helical CT. [9393154] AJR Am J Roentgenol 169(6): 1507-15 (1997)
1992 102	Differential diagnosis of hyperintense liver lesions on T1-weighted MR images. [1329456] AJR Am J Roentgenol 159(5): 1017-20 (1992)
1990 103	Liver tumor imaging: current concepts. [2117343] AJR Am J Roentgenol 155(3): 473-84 (1990)
2008 104	Exophytic benign and malignant hepatic tumors: CT imaging features. [18253078] Korean J Radiol 9(1): 67-75 (2008)
2009 105	MR imaging of hypervascular liver masses: a review of current techniques. [19325055] Radiographics 29(2): 385-402 (2009)
2008 106	Cirrhosis-associated hepatocellular nodules: correlation of histopathologic and MR imaging features. [18480482] Radiographics 28(3): 747-69 (2008)
2008 107	Spectrum of CT findings after radiofrequency ablation of hepatic tumors. [18349446] Radiographics 28(2): 379-90; discussion 390-2 (2008)
2008 108	Recent advances in transarterial therapy of primary and secondary liver malignancies. [18203933] Radiographics 28(1): 101-17 (2008)
2008 109	Multimodality imaging following 90Y radioembolization: a comprehensive review and pictorial essay. [18203932] Radiographics 28(1): 81-99 (2008)
2005 110	Complications of percutaneous radiofrequency ablation for hepato-cellular carcinoma: imaging spectrum and management. [16227497] Radiographics 25 Suppl 1(-): S57-68 (2005)
2005 111	Yttrium-90 microsphere therapy for hepatic malignancy: devices, indications, technical considerations, and potential complications. [16227496] Radiographics 25 Suppl 1(-): S41-55 (2005)
2005 112	Staging and current treatment of hepatocellular carcinoma. [16227495] Radiographics 25 Suppl 1(-): S3-23 (2005)
2005 113	Focal hepatic lesions: diagnostic value of enhancement pattern approach with contrast-enhanced 3D gradient-echo MR imaging. [16160113] Radiographics 25(5): 1299-320 (2005)
2005 114	Fat-containing lesions of the liver: radiologic-pathologic correlation. [15798052] Radiographics 25(2): 321-31 (2005)
2003 115	Hepatocellular carcinoma treated with radio-frequency ablation: spectrum of imaging findings. [12533646] Radiographics 23(1): 107-21 (2003)
2002 116	Transcatheter arterial chemoembolization for hepatocellular carcinoma: anatomic and hemodynamic considerations in the hepatic artery and portal vein. [12235337] Radiographics 22(5): 1077-91 (2002)
2002 117	Transhepatic portal vein embolization: anatomy, indications, and technical considerations. [12235336] Radiographics 22(5): 1063-76 (2002)
2002 118	Benign versus malignant hepatic nodules: MR imaging findings with pathologic correlation. [12235331] Radiographics 22(5): 1023-36; discussion 1037-9 (2002)
2000 119	Minimally invasive treatment of malignant hepatic tumors: at the threshold of a major breakthrough. [10682768] Radiographics 20(1): 9-27 (2000)
1999 120	Fibrolamellar carcinoma of the liver: radiologic-pathologic correlation. [10194790] Radiographics 19(2): 453-71 (1999)
1999 121	CT and MR imaging of benign hepatic and biliary tumors. [10194789] Radiographics 19(2): 431-51 (1999)
1999 122	Chemoembolization of hepatic neoplasms: safety, complications, and when to worry. [10194787] Radiographics 19(2): 399-414 (1999)
1998 123	The Rocky liver: radiologic-pathologic correlation of calcified hepatic masses. [9599391] Radiographics 18(3): 675-85; quiz 726 (1998)
1994 124	Primary liver neoplasms: MR imaging with pathologic correlation. [8066263] Radiographics 14(3): 459-82 (1994)
1993 125	From the archives of the AFIP. Infantile hemangioendothelioma of the liver revisited. [8316672] Radiographics 13(3): 657-70 (1993)
1989 126	The CT appearance of cystic masses of the liver. [2538868] Radiographics 9(2): 307-22 (1989)
1988 127	Undiversion of the urinary tract: the pre-and postoperative evaluation. [3283866] Radiographics 8(2): 213-33 (1988)
1998 128	Diagnostic imaging and interventional therapy of hepatocellular carcinoma. [9828792] Br J Radiol 71(848): 808-18 (1998)
2007 129	Hepatocellular carcinoma in patients with nonalcoholic fatty liver disease: helical CT and MR imaging findings with clinical-pathologic comparison. [17356175] Radiology 243(2): 422-30 (2007)
2005 130	Neoangiogenesis and sinusoidal capillarization in hepatocellular carcinoma: correlation between dynamic CT and density of tumor microvessels. [16244261] Radiology 237(2): 529-34 (2005)
2002 131	Angiographic classification of hepatic hemangiomas in infants. [11867787] Radiology 222(3): 693-8 (2002)
2002 132	Primary hepatic angiosarcoma: findings at CT and MR imaging. [11867783] Radiology 222(3): 667-73 (2002)
1999 133	Fibrolamellar hepatocellular carcinoma: imaging and pathologic findings in 31 recent cases. [10551212] Radiology 213(2): 352-61 (1999)
2009 134	Significance of des-gamma-carboxy prothrombin production in hepatocellular carcinoma. [20035286] Acta Med Okayama 63(6): 299-304 (2009)
2009 135	An overview of hepatocellular carcinoma study by omics-based methods. [19129945] Acta Biochim Biophys Sin (Shanghai) 41(1): 1-15 (2009)
2010 136	Hepatocellular carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. [20555104] Ann Oncol 21 Suppl 5(-): v59-64 (2010)
2009 137	Hepatocellular carcinoma: ESMO clinical recommendations for diagnosis, treatment and follow-up. [19454459] Ann Oncol 20 Suppl 4(-): 41-5 (2009)
2010 138	Management of small hepatocellular carcinoma: a review of transplantation, resection, and ablation. [20405327] Ann Surg Oncol 17(5): 1226-33 (2010)
2011 139	Advanced hepatocellular carcinoma. Review of targeted molecular drugs. [21301005] Ann Hepatol 10(1): 21-7 (2011)
2010 140	Prediction of progression-free survival in patients presenting with hepatocellular carcinoma within the Milan criteria. [20373461] Liver Transpl 16(4): 503-12 (2010)
2010 141	The Milan criteria: no room on the metro for the king? [20209585] Liver Transpl 16(3): 252-5 (2010)
2004 142	Liver transplantation in patients with hepatocellular carcinoma. [14762845] Liver Transpl 10(2 Suppl 1): S81-5 (2004)
2004 143	Percutaneous ablation of hepatocellular carcinoma: state-of-the-art. [14762847] Liver Transpl 10(2 Suppl 1): S91-7 (2004)
2004 144	Prevention and treatment of hepatocellular carcinoma. [14762850] Liver Transpl 10(2 Suppl 1): S111-4 (2004)
2004 145	The Barcelona approach: diagnosis, staging, and treatment of hepatocellular carcinoma. [14762851] Liver Transpl 10(2 Suppl 1): S115-20 (2004)
2004 146	Focus on dysplastic nodules and early hepatocellular carcinoma: an Eastern point of view. [14762831] Liver Transpl 10(2 Suppl 1): S3-8 (2004)
2004 147	Hepatocellular nodules in cirrhosis: focus on diagnostic criteria on liver biopsy. A Western experience. [14762832] Liver Transpl 10(2 Suppl 1): S9-15 (2004)
2004 148	The current status of imaging diagnosis of hepatocellular carcinoma. [14762834] Liver Transpl 10(2 Suppl 1): S20-5 (2004)
2004 149	Fine needle biopsy of focal liver lesions: the hepatologist's point of view. [14762835] Liver Transpl 10(2 Suppl 1): S26-9 (2004)
2004 150	Hepatectomy for hepatocellular carcinoma: patient selection and postoperative outcome. [14762838] Liver Transpl 10(2 Suppl 1): S39-45 (2004)
2004 151	The surgical approach to HCC: our progress and results in Japan. [14762839] Liver Transpl 10(2 Suppl 1): S46-52 (2004)
2004 152	Surgical resection of hepatocellular carcinoma. Post-operative outcome and long-term results in Europe: an overview. [14762841] Liver Transpl 10(2 Suppl 1): S58-63 (2004)
2004 153	Surgical treatment of hepatocellular carcinoma: similar long-term results despite geographic variations. [14762844] Liver Transpl 10(2 Suppl 1): S74-80 (2004)
2008 154	Liver tumors: pediatric population. [18975283] Liver Transpl 14(11): 1545-56 (2008)
2007 155	Clinical and molecular classification of hepatocellular carcinoma. [17969094] Liver Transpl 13(11 Suppl 2): S13-6 (2007)
2011 156	P16 gene hypermethylation and hepatocellular carcinoma: a systematic review and meta-analysis. [21799651] World J Gastroenterol 17(25): 3043-8 (2011)
2011 157	Contrast-enhanced multiple-phase imaging features in hepatic epithelioid hemangioendothelioma. [21941423] World J Gastroenterol 17(30): 3544-53 (2011)
2011 158	Surgicopathological classification of hepatic space-occupying lesions: a single-center experience with literature review. [21633636] World J Gastroenterol 17(19): 2372-8 (2011)
2011 159	Nodular regenerative hyperplasia: evolving concepts on underdiagnosed cause of portal hypertension. [21472097] World J Gastroenterol 17(11): 1400-9 (2011)
2011 160	Therapeutic options for intermediate-advanced hepatocellular carcinoma. [21483627] World J Gastroenterol 17(13): 1685-9 (2011)
2010 161	Undifferentiated liver embryonal sarcoma in adults: a report of four cases and literature review. [20872975] World J Gastroenterol 16(37): 4725-32 (2010)
2010 162	Clinical features of hepatitis B virus-related hepatocellular carcinoma. [20503445] World J Gastroenterol 16(20): 2463-7 (2010)
2010 163	Present and future possibilities for early diagnosis of hepatocellular carcinoma. [20101765] World J Gastroenterol 16(4): 418-24 (2010)
2010 164	Surgical treatment for liver cancer. [20180230] World J Gastroenterol 16(8): 927-33 (2010)
2007 165	Genotype phenotype classification of hepatocellular adenoma. [17569132] World J Gastroenterol 13(19): 2649-54 (2007)
2007 166	Perivascular epithelioid cell tumor of the liver: a report of two cases and review of the literature. [17907305] World J Gastroenterol 13(41): 5537-9 (2007)
2007 167	Genetics of hepatocellular carcinoma. [17511024] World J Gastroenterol 13(16): 2271-82 (2007)
2009 168	Liver transplantation for hepatocellular carcinoma. [19938188] World J Gastroenterol 15(44): 5511-6 (2009)
2003 169	Telangiectatic focal nodular hyperplasia: US, CT, and MR imaging findings with histopathologic correlation in 13 cases. [12819340] Radiology 228(2): 465-72 (2003)
2005 170	Advanced hepatocellular carcinoma: treatment with high-intensity focused ultrasound ablation combined with transcatheter arterial embolization. [15858105] Radiology 235(2): 659-67 (2005)
2008 171	MR Imaging of hepatocellular carcinoma in the cirrhotic liver: challenges and controversies. [18430871] Radiology 247(2): 311-30 (2008)
2008 172	Human oncogenic viruses: hepatitis B and hepatitis C viruses and their role in hepatocarcinogenesis. [18605975] Biochemistry (Mosc) 73(5): 504-13 (2008)
2009 173	Vascular endothelial growth factor in the management of hepatocellular carcinoma: a review of literature. [19637355] Cancer 115(21): 4895-906 (2009)
2011 174	Benign liver masses and lesions in children: 53 cases over 12 years. [21991714] Isr Med Assoc J 13(9): 542-7 (2011)
2010 175	Sorafenib for the treatment of advanced hepatocellular carcinoma. [20507799] Health Technol Assess 14 Suppl 1(-): 17-21 (2010)
2010 176	Focal nodular hyperplasia, hepatocellular adenomas: past, present, future. [20537479] Gastroenterol Clin Biol 34(6-7): 355-8 (2010)
2006 177	Hepatocellular carcinoma (primary cancer of the liver). [17151564] Gastroenterol Clin Biol 30 Spec No 2(-): 2S57-2S61 (2006)
2009 178	Natural history and therapeutic management of recurrent hepatocellular carcinoma after liver transplantation. [19398289] Gastroenterol Clin Biol 33(5): 361-9 (2009)
2011 179	Treatment options in hepatocellular carcinoma today. [21482502] Scand J Surg 100(1): 22-9 (2011)
2007 180	Distinguishing benign from malignant liver tumours. [17921080] Cancer Imaging 7 Spec No A(-): S1-14 (2007)
2007 181	Post-treatment imaging of liver tumours. [17921098] Cancer Imaging 7 Spec No A(-): S28-36 (2007)
2006 182	Current staging of hepatocellular carcinoma: imaging implications. [16829469] Cancer Imaging 6(-): 83-94 (2006)
2008 183	Thermal ablation of hepatocellular carcinoma. [18331969] Cancer Imaging 8(-): 19-26 (2008)
2004 184	Approaching focal liver lesions. [15449988] Rev Esp Enferm Dig 96(8): 567-73; 573-7 (2004)
2011 185	Usefulness of contrast enhanced ultrasound guidance in percutaneous biopsies of liver tumors. [21725517] J Gastrointestin Liver Dis 20(2): 191-6 (2011)
2010 186	Solitary fibrous liver tumor: is surgical approach the best option? [20361081] J Gastrointestin Liver Dis 19(1): 81-4 (2010)
2008 187	Vascular changes in hepatocellular carcinoma. [18484619] Anat Rec (Hoboken) 291(6): 721-34 (2008)
2010 188	Hepatocellular carcinoma: review of current treatment with a focus on targeted molecular therapies. [21180590] Therap Adv Gastroenterol 3(1): 55-66 (2010)
2009 189	Surgery for malignant liver tumors. [19841555] J Cancer Res Ther 5(3): 154-60 (2009)
2010 190	The role of contrast enhanced ultrasound (CEUS) in the assessment of liver nodules in patients with cirrhosis. [21173943] Med Ultrason 12(2): 145-9 (2010)
2011 191	Contrast enhanced ultrasound for the diagnosis of liver hemangiomas in clinical practice. [21655534] Med Ultrason 13(2): 95-101 (2011)
2011 192	Contrast enhanced ultrasound for the characterization of hepatocellular carcinoma. [21655536] Med Ultrason 13(2): 108-13 (2011)
2011 193	Targeting insulin-like growth factor axis in hepatocellular carcinoma. [21729319] J Hematol Oncol 4(-): 30 (2011)
2006 194	Efficiency of MR imaging in the detection of malignant liver lesions. [16538579] Diagn Interv Radiol 12(1): 17-21 (2006)
2007 195	2005 PRETEXT: a revised staging system for primary malignant liver tumours of childhood developed by the SIOPEL group. [17186233] Pediatr Radiol 37(2): 123-32; quiz 249-50 (2007)
2010 196	Radiofrequency ablation of liver tumors (I): biological background. [20234157] Medicina (Kaunas) 46(1): 13-7 (2010)
2010 197	Radiofrequency ablation of liver tumors (II): clinical application and outcomes. [20440080] Medicina (Kaunas) 46(2): 81-8 (2010)
2002 198	Molecular aspects of hepatic carcinogenesis. [11896411] Rev Inst Med Trop Sao Paulo 44(1): 39-48 (2002)
2010 199	Hepatic epithelioid haemangioendothelioma: is transplantation the only treatment option? [20887322] HPB (Oxford) 12(8): 546-53 (2010)
2008 200	Treatment response to transcatheter arterial embolization and chemoembolization in primary and metastatic tumors of the liver. [19088924] HPB (Oxford) 10(6): 396-404 (2008)
2011 201	Inflammatory pseudo-tumor of the liver: a rare pathological entity. [21255461] World J Surg Oncol 9(-): 5 (2011)
2011 202	Solitary fibrous tumor of the liver: a case report. [21443810] World J Surg Oncol 9(-): 37 (2011)
2008 203	Primary carcinoid tumors of the liver. [18727836] World J Surg Oncol 6(-): 91 (2008)
2011 204	Liver cancer: Targeted future options. [21423913] World J Hepatol 3(2): 38-44 (2011)
2011 205	Radiofrequency ablation of liver tumors: Actual limitations and potential solutions in the future. [21307982] World J Hepatol 3(1): 8-14 (2011)
2009 206	Inflammatory myofibroblastic tumor of the liver: a case report. [19530046] Turk J Gastroenterol 20(2): 129-34 (2009)
2011 207	Advances in liver cancer antibody therapies: a focus on glypican-3 and mesothelin. [21942912] BioDrugs 25(5): 275-84 (2011)
2011 208	Clinical features of infantile hepatic hemangioendothelioma. [21949521] Korean J Pediatr 54(6): 260-6 (2011)
2008 209	Receiver operating characteristic analysis of diffusion-weighted magnetic resonance imaging in differentiating hepatic hemangioma from other hypervascular liver lesions. [18830105] J Comput Assist Tomogr 32(5): 750-6 (2008)
2008 210	Liver stem cells and tgf-Beta in hepatic carcinogenesis. [19343145] Gastrointest Cancer Res 2(4 Suppl): S27-30 (2008)
2011 211	Primary glomus tumor of the liver: a rare case report and review of the literature. [21934228] Indian J Pathol Microbiol 54(3): 584-7 (2011)
2011 212	Primary hepatic gastrinoma: Report of a case and review of literature. [21607163] World J Gastrointest Pathophysiol 2(2): 26-30 (2011)
2010 213	Proliferative and nonproliferative lesions of the rat and mouse hepatobiliary system. [21191096] Toxicol Pathol 38(7 Suppl): 5S-81S (2010)
2010 214	Spontaneous rupture of hepatic hemangiomas: A review of the literature. [21191518] World J Hepatol 2(12): 428-33 (2010)
PMC 215	Fiducial placement for stereotactic body radiation therapy under only endoscopic ultrasonography guidance in pancreatic and hepatic malignancy: practical feasibility and safety. [24516706] Gut Liver 8(1):88-93 (2014)
PMC 216	Clinical features, image findings, and prognosis of inflammatory pseudotumor of the liver: a multicenter experience of 45 cases. [24516702] Gut Liver 8(1):58-63 (2014)
PMC 217	Changes in the management of benign liver tumours: an analysis of 285 patients. [23297727] HPB (Oxford) 15(2):156-63 (2013)
PMC 218	Novel hepatocellular carcinoma molecules with prognostic and therapeutic potentials. [24574801] World J Gastroenterol 20(5):1268-88 (2014)
PMC 219	Treatment of metastatic liver tumors using stereotactic ablative radiotherapy. [24578789] World J Radiol 6(2):18-25 (2014)
PMC 220	Management of hepatocellular adenoma: comparison of resection, embolization and observation. [23374365] HPB (Oxford) 15(3):235-43 (2013)
PMC 221	Microwave ablation of hepatic malignancy. [24436518] Semin Intervent Radiol 30(1):56-66 (2013)
PMC 222	Radiofrequency ablation of liver tumors. [24436517] Semin Intervent Radiol 30(1):49-55 (2013)
PMC 223	Transhepatic therapies for metastatic uveal melanoma. [24436516] Semin Intervent Radiol 30(1):39-48 (2013)
PMC 224	Successful management of multi-focal hepatic infantile hemangioendothelioma using TACE/surgery followed by maintenance metronomic therapy. [22605610] BMJ Case Rep 2012(): (2012)
PMC 225	Nested stromal-epithelial tumour of the liver: An unusual liver entity. [24672646] World J Hepatol 6(3):155-9 (2014)
PMC 226	Complications of radiofrequency ablation of hepatic tumors: Frequency and risk factors. [24672640] World J Hepatol 6(3):107-13 (2014)
PMC 227	Chromophobe hepatocellular carcinoma with abrupt anaplasia: a proposal for a new subtype of hepatocellular carcinoma with unique morphological and molecular features. [23640129] Mod Pathol 26(12):1586-93 (2013)
PMC 228	Multi-slice computed tomography manifestations of hepatic epithelioid angiomyolipoma. [2469666] World J Gastroenterol 20(12):3364-8 (2014)

Downloaded from http://www.kidney.de - The Database of Free Medical Reviews - The Metatextbook of Medicine - Ossip Groth

All Medline data shown were primarily retrieved from MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Fatal error: Uncaught Error: Call to undefined function mysql_connect() in C:\Inetpub\vhosts\kidney.de\httpdocs\bdom\Liver (Neoplasia).php:92 Stack trace: #0 {main} thrown in C:\Inetpub\vhosts\kidney.de\httpdocs\bdom\Liver (Neoplasia).php on line 92